198 related articles for article (PubMed ID: 38372344)
1. Myocardial Ischemia/Reperfusion Injury: Mechanism and Targeted Treatment for Ferroptosis.
Deng Y; Chen Q; Wang T; Wang S; Li R; Wang Y; Zhang J; Gan J; Guo M
Anatol J Cardiol; 2024 Feb; 28(3):133-41. PubMed ID: 38372344
[TBL] [Abstract][Full Text] [Related]
2. The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury.
Zhang S; Yan F; Luan F; Chai Y; Li N; Wang YW; Chen ZL; Xu DQ; Tang YP
Phytomedicine; 2024 Jul; 129():155649. PubMed ID: 38653154
[TBL] [Abstract][Full Text] [Related]
3. GDF15 restrains myocardial ischemia-reperfusion injury through inhibiting GPX4 mediated ferroptosis.
Gao Q; Li C; Zhong P; Yu Y; Luo Z; Chen H
Aging (Albany NY); 2024 Jan; 16(1):617-626. PubMed ID: 38206295
[TBL] [Abstract][Full Text] [Related]
4. The molecular mechanisms and potential drug targets of ferroptosis in myocardial ischemia-reperfusion injury.
Zhang CH; Yan YJ; Luo Q
Life Sci; 2024 Mar; 340():122439. PubMed ID: 38278348
[TBL] [Abstract][Full Text] [Related]
5. Broadening horizons: The role of ferroptosis in myocardial ischemia-reperfusion injury.
Zhao K; Chen X; Bian Y; Zhou Z; Wei X; Zhang J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2269-2286. PubMed ID: 37119287
[TBL] [Abstract][Full Text] [Related]
6. Relationship between ferroptosis and mitophagy in cardiac ischemia reperfusion injury: a mini-review.
Liu C; Li Z; Li B; Liu W; Zhang S; Qiu K; Zhu W
PeerJ; 2023; 11():e14952. PubMed ID: 36935924
[TBL] [Abstract][Full Text] [Related]
7. Potential relationship between autophagy and ferroptosis in myocardial ischemia/reperfusion injury.
Yang Y; Lin X
Genes Dis; 2023 Nov; 10(6):2285-2295. PubMed ID: 37554184
[TBL] [Abstract][Full Text] [Related]
8. YAP Facilitates NEDD4L-Mediated Ubiquitination and Degradation of ACSL4 to Alleviate Ferroptosis in Myocardial Ischemia-Reperfusion Injury.
Qiu M; Yan W; Liu M
Can J Cardiol; 2023 Nov; 39(11):1712-1727. PubMed ID: 37541340
[TBL] [Abstract][Full Text] [Related]
9. Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway.
Yang T; Liu H; Yang C; Mo H; Wang X; Song X; Jiang L; Deng P; Chen R; Wu P; Chen A; Yan J
Drug Des Devel Ther; 2023; 17():2495-2511. PubMed ID: 37637264
[TBL] [Abstract][Full Text] [Related]
10. A Novel Insight Into the Fate of Cardiomyocytes in Ischemia-Reperfusion Injury: From Iron Metabolism to Ferroptosis.
Li JY; Liu SQ; Yao RQ; Tian YP; Yao YM
Front Cell Dev Biol; 2021; 9():799499. PubMed ID: 34926476
[TBL] [Abstract][Full Text] [Related]
11. Fucoxanthin alleviated myocardial ischemia and reperfusion injury through inhibition of ferroptosis
Yan J; Li Z; Liang Y; Yang C; Ou W; Mo H; Tang M; Chen D; Zhong C; Que D; Feng L; Xiao H; Song X; Yang P
Food Funct; 2023 Nov; 14(22):10052-10068. PubMed ID: 37861458
[No Abstract] [Full Text] [Related]
12. Acetylation, ferroptosis, and their potential relationships: Implications in myocardial ischemia-reperfusion injury.
Yang Y; Ma M; Su J; Jia L; Zhang D; Lin X
Am J Med Sci; 2023 Sep; 366(3):176-184. PubMed ID: 37290744
[TBL] [Abstract][Full Text] [Related]
13. Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management (Review).
He J; Liu D; Zhao L; Zhou D; Rong J; Zhang L; Xia Z
Exp Ther Med; 2022 Jun; 23(6):430. PubMed ID: 35607376
[TBL] [Abstract][Full Text] [Related]
14. FOXN4 affects myocardial ischemia-reperfusion injury through HIF-1α/MMP2-mediated ferroptosis of cardiomyocytes.
Wang J; Deng M; Yang J; Zhou X; Yang P; Li Y; Zhang G
Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):214-225. PubMed ID: 37605566
[TBL] [Abstract][Full Text] [Related]
15. Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis
Chen W; Zhang Y; Wang Z; Tan M; Lin J; Qian X; Li H; Jiang T
Front Pharmacol; 2023; 14():1078205. PubMed ID: 36891270
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis: Opportunities and Challenges in Myocardial Ischemia-Reperfusion Injury.
Zhao WK; Zhou Y; Xu TT; Wu Q
Oxid Med Cell Longev; 2021; 2021():9929687. PubMed ID: 34725566
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of DYRK1a in myocardial ischemia-reperfusion injury by regulating ferroptosis of cardiomyocytes.
Wang J; Xu RM; Cao QM; Ma BC; Zhang H; Hao HP
Kaohsiung J Med Sci; 2023 Dec; 39(12):1190-1199. PubMed ID: 37702441
[TBL] [Abstract][Full Text] [Related]
18. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D
Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of ferroptosis regulating oxidative stress and energy metabolism in myocardial ischemia-reperfusion injury and a novel perspective of natural plant active ingredients for its treatment.
Zhang T; Deng W; Deng Y; Liu Y; Xiao S; Luo Y; Xiang W; He Q
Biomed Pharmacother; 2023 Sep; 165():114706. PubMed ID: 37400352
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities in the SIRT1-SIRT3 axis promote myocardial ischemia-reperfusion injury through ferroptosis caused by silencing the PINK1/Parkin signaling pathway.
Liao Y; Ke B; Long X; Xu J; Wu Y
BMC Cardiovasc Disord; 2023 Nov; 23(1):582. PubMed ID: 38012584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
